Fungal Species:  Lichtheimia corymbifera

Catastrophic Cerebral Infarctions in a Pediatric Patient with Acute Lymphoblastic Leukemia Due to Mucorales Infection

mycolabadmin

An 11-year-old girl with leukemia undergoing chemotherapy developed a severe fungal infection called mucormycosis caused by Lichtheimia ramosa. The infection spread rapidly from her sinuses to her eyes and brain, causing multiple blood clots in brain arteries and a massive stroke within just five days. Despite emergency surgery to remove the clots, the infection had progressed too far and the patient sadly did not survive, highlighting how dangerous this fungal infection can be in children with weakened immune systems.

Read More »

Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)

mycolabadmin

This research examined dangerous mold infections (Mucormycosis) that became more common after COVID-19. Scientists identified the types of molds causing these infections in Iran by testing 116 patient samples and 65 soil samples from across the country. They tested these molds against 13 different antifungal medications to find which drugs work best. The results showed that amphotericin B and posaconazole were the most effective medications, and patient samples were more susceptible to these drugs than environmental soil samples.

Read More »

Compatible traits of oleaginous Mucoromycota fungi for lignocellulose-based simultaneous saccharification and fermentation

mycolabadmin

Researchers tested nine types of fungi to find which ones are best at producing oils from plant waste for making biofuels. They tested how well each fungus could handle higher temperatures and break down cellulose, which is the main component of plant material. Lichtheimia corymbifera was the clear winner because it could grow at higher temperatures while still breaking down plant material efficiently, making it ideal for the combined process of breaking down and fermenting plant waste.

Read More »

Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)

mycolabadmin

This study examined dangerous mold infections called mucormycosis that became more common during the COVID-19 pandemic, particularly in Iran. Researchers tested over 180 fungal samples from patients and soil to understand which types of molds cause infections and which antifungal medicines work best against them. They found that two medicines, amphotericin B and posaconazole, were most effective, while fungi from soil samples were often more resistant to treatment than those from infected patients. This research helps doctors choose the right treatments for patients with these serious infections.

Read More »

Updates on the Taxonomy of Mucorales with an Emphasis on Clinically Important Taxa

mycolabadmin

This research provides an updated understanding of how we classify and identify an important group of fungi called Mucorales, which can cause serious infections in humans. The findings help medical professionals better identify these fungi and understand their potential risks. Impacts on everyday life: • Improved diagnosis of fungal infections in hospitals • Better understanding of food spoilage caused by these fungi • Enhanced safety in food fermentation processes (like soy products) • More effective prevention of fungal infections in immunocompromised patients • Better quality control in biotechnology applications using these fungi

Read More »
Scroll to Top